TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Swedish Orphan Biovitrum International AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
15,618
|
15,985
|
17,057 |
Financial expenses |
62,253
|
65,689
|
70,958 |
Earnings before taxes |
-43,743
|
-63,814
|
-108,407 |
EBITDA |
14,729
|
876
|
-22,213 |
Total assets |
3,787,406
|
4,014,697
|
4,207,945 |
Current assets |
23,141
|
282,139
|
137,828 |
Current liabilities |
69,342
|
9,956
|
11,806 |
Equity capital |
937,838
|
824,957
|
782,902 |
- share capital |
418
|
416
|
452 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
24.8%
|
20.5%
|
18.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
-280.1%
|
-399.2%
|
-635.6% |
Return on assets (ROA) |
0.5%
|
0.0%
|
-0.9% |
Current ratio |
33.4%
|
2833.9%
|
1167.4% |
Return on equity (ROE) |
-4.7%
|
-7.7%
|
-13.8% |
Change turnover |
-449
|
309
|
-7,637 |
Change turnover % |
-3%
|
2%
|
-31% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.